Table 4 Endometrial thickness and K-ras mutaion in tamoxifen-treated breast cancer patients with and without vaginal bleeding
Pateints with vaginal bleeding | Patients without vaginal bleeding | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
K-ras mutation | K-ras mutation | |||||||||
Endometrial thickness (cm) | No. of cases | (−) | Low | High | Positive rate (%) | No. of cases | (−) | Low | High | Positive rate (%) |
−0.5 | 2 | 1 | 0 | 1 | 50.0 | 32 | 15 | 12 | 5 | 53.1 |
0.6–0.9 | 1 | 1 | 0 | 0 | 0.0 | 27 | 20 | 4 | 3 | 25.9 |
1.0− | 11 | 4 | 3 | 4* | 63.6 | 13 | 10 | 3 | 0 | 23.1 |
Total | 14 | 6 | 3 | 5 | 57.1 | 72 | 45 | 19 | 8 | 37.5 |
